Inducible-nitric oxide synthase (iNOS) is constitutively expressed in human duodenal enterocytes; its activity is increased in patients with untreated celiac disease [38,39,40] and is partially corrected when patients are treated with GFD [41,42]. The gene discussed is NOS2; the disease is celiac disease.